22a Setmana de la Ciència
El estudio de la diabetes con órganos en un chip
Search Results for:
22a Setmana de la Ciència
El estudio de la diabetes con órganos en un chip
IBEC’s newest group leader will advance drug delivery systems
IBEC gains a new group leader this month, with Prof. Silvia Muro joining the institute as an ICREA research professor to lead her Targeted Therapeutics and Nanodevices group.
In her new position, she will carry out research into macromolecular nano-assemblies which can be loaded with drugs to target the chronic conditions that affect our pediatric and ageing populations, such as neurodegenerative, cardiovascular or metabolic diseases, as well as cancer.
Prof. Muro spent the last nine years at the University of Maryland, first as an Assistant Professor and then as a tenured Associate Professor with a joint appointment in the Fischell Department of Bioengineering and the Institute for Bioscience and Biotechnology Research.
Senior Technician Position in Nanobioengineering Research Group
Application Deadline: 05/12/2017
Ref: TEC-JM
The Nanobioengineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Senior Technical Position for cell-based microfluidic assay development for personalized cancer treatment.
Oportunidades de financiación en I+D+i
NANOMED Spain, en colaboración con el CDTI, EIT Health Spain y Acció, organiza esta jornada que tiene el objetivo de dar a conocer diferentes instrumentos de financiación de actividades empresariales … Read more
Oportunidades de financiación en I+D+i
NANOMED Spain, en colaboración con el CDTI, EIT Health Spain y Acció, organiza esta jornada que tiene el objetivo de dar a conocer diferentes instrumentos de financiación de actividades empresariales … Read more
Oportunidades de financiación en I+D+i
NANOMED Spain, en colaboración con el CDTI, EIT Health Spain y Acció, organiza esta jornada que tiene el objetivo de dar a conocer diferentes instrumentos de financiación de actividades empresariales … Read more
Oportunidades de financiación en I+D+i
NANOMED Spain, en colaboración con el CDTI, EIT Health Spain y Acció, organiza esta jornada que tiene el objetivo de dar a conocer diferentes instrumentos de financiación de actividades empresariales … Read more
FUNDALUCE grant for IBEC research into vision restoration
IBEC group leader and ICREA professor Pau Gorostiza has won the research grant ‘FUNDALUCE 2016’ for a project that aims to develop prosthetic molecular switches that could replace degenerated photoreceptors in the retina to restore vision.
“Fotoconmutadores covalentes para el control remoto de receptores endógenos”, which will be carried out with collaborators at IQAC-CSIC, the Universidad Miguel Hernández, Universidad de Alcalá de Henares and the Instituto de Neurociencias de Alicante, proposes the concept of nanoprosthesis: that if a functional characteristic of an organ or tissue is regulated by a given receptor, it should be possible to use directed covalent photoswitches to control that particular receptor with light, thereby manipulating their function.
IBEC investigators show that physical forces activate genes involved in cancer
In their effort to shed light on the role that physical forces play in the body, Pere Roca-Cusachs’ group at IBEC has shown how these forces ‘switch on’ the expression of genes that may result in cancer.
Cells apply mechanical forces to their surrounding tissue, and this mechanical effect is crucial for tissue function. In diseases such as cancer or liver and lung fibrosis, tissue rigidity and mechanical forces increase, promoting the progression of the disease.